U300, a novel long-acting insulin formulation

  • Gemma Sutton, Joan Minguet, Carmen Ferrero, Peter Bramlage
  • Expert Opinion on Biological Therapy, October 2014, Informa Healthcare
  • DOI: 10.1517/14712598.2014.970633

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1517/14712598.2014.970633

The following have contributed to this page: Peter Bramlage